| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
SiNtx Technologies, Inc.$1.92
-0.07 (-3.52%)
Market Cap
10.32 M
EPS
-5.64
P/E Ratio
-
Value Trade
1.48 M
SEC Financials
Q1 2026Dilution Risk
Revenue
380.00 K
R&D Expenses
364.00 K
Operating CF
-2.49 M
Total Assets
7.81 M
Total Liabilities
6.91 M
Equity
904.00 K
D/E Ratio
12,345
-1.65 %
Week
-9.81 %
1 Month
-25.31 %
3 Month
-26.91 %
6 Month
-99.99 %
5 Year
-100 %
All Time
Cash Data
Cash Position
1.89 M
Monthly Burn
830.00 K
Runway
1.2 mo
Burn Trend
SEC Filing
May 15, 2026
Overview
Volume
22.25 K
52 Week Range
1.99 - 6.78
% held by Insiders
23.36 %
% held by Institutions
10.01 %
Enterprise Value
11.70 M
Total Shares
4.00 M
Short %
8.6 %
Float Shares
2.27 M
Company Description
locked
Upcoming Catalyst
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in SINT
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
SiNtx Technologies, Inc. (SINT) Analyst Ratings & Price Targets
Symbol
Firm
Rating
Action
Price Target
Upside
date
SINT
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
SINT
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
SINT
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
SINT Stock Forecast & Analyst Consensus
BUY
Analyst Ratings
Buy65.0%
Hold25.0%
Sell10.0%
Price Target Trend
Average$24.00
Low$18.00
High$32.00
SINT Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
SINTSINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
SINTX Technologies, Inc. has announced a capital raise of approximately $5.0 million, including a $4.5 million private placement priced at-the-market. The offering involves issuing 1,882,845 shares of common stock along with corresponding warrants to accredited investors. The funds are earmarked for general corporate purposes, especially in advancing the company's silicon nitride technology. The financing reflects strong investor support and is expected to enhance SINTX's strategic capabilities in the medical application sector.
Read more →SINTSINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride-PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants Milestone enables immediate production of SiN/PEEK custom devices
SINTX Technologies has signed a significant supply agreement with EVONIK to manufacture its proprietary silicon nitride-PEEK (SiN/PEEK) compound. This collaboration allows for the immediate production of AI-assisted, 3D-printed, patient-specific implants at SINTX's facility in the U.S. The agreement will enable SINTX to respond to physician requests for humanitarian-use vertebral body replacement implants, addressing critical needs in trauma and oncology. The SiN/PEEK compound is anticipated to offer advantages over standard PEEK materials.
Read more →SINTSINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies Company underscores its strengthened liquid
SINTX Technologies, Inc. reported a pivotal business update for the third quarter of 2025, highlighting key achievements including FDA clearance for its SINAPTIC Foot & Ankle Osteotomy Wedge System and its first commercial revenue from OsseoSculpt. The company's financial highlights show a reduction in operating expenses and improved liquidity through a recent financing activity. However, revenue has decreased compared to the previous year, raising concerns despite strong operational efficiencies and portfolio expansions. Looking ahead, SINTX plans to focus on launching the SINAPTIC wedge system and expanding clinical engagement.
Read more →SINTSINTX Technologies Submits FDA 510(k) for Silicon Nitride Foot & Ankle Medical Devices Advanced Material Science Meets Surgical Precision in Groundbreaking New Platform in Reconstructive Foot & Ankl
SINTX Technologies has submitted a 510(k) premarket notification to the FDA for its silicon nitride osteotomy wedges, marking its entry into the reconstructive foot and ankle market. The company emphasizes the advanced biomaterial's benefits, including improved bone integration and reduced infection rates, as well as proprietary implant designs aimed at enhancing surgical efficiency. This development is projected to drive significant revenue growth, with expectations for strong early adoption by healthcare providers. However, the company acknowledges that the approval process and commercialization may encounter uncertainties.
Read more →SINTSINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market Strategic Acquisition Brings Patented Implant Designs, Seasoned Executive Team, and Near-Term Commercial Oppor
SINTX Technologies announced the acquisition of SiNAPTIC Holdings' surgical business assets, enabling entry into the $1.3 billion foot and ankle fusion market. This acquisition includes all intellectual property and product designs related to six differentiated implant systems, aiming to accelerate commercial growth. The deal, viewed as transformative, will likely shift SINTX's focus from R&D towards revenue generation, assisted by SiNAPTIC's experienced team. However, achieving success will depend on effective commercialization and navigating regulatory hurdles.
Read more →SINTSINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market
SINTX Technologies has announced the issuance of an international patent for silicon nitride applications in agriculture, specifically for antimicrobial treatment and plant protection. The company is expanding into the agribiotech market with the formation of a subsidiary, SINTX Agribiotech, which will focus on developing sustainable agricultural technologies. Expected growth in the global antimicrobial fertilizer market highlights the potential for silicon nitride, which has shown promising results in preventing crop diseases. Nevertheless, the company acknowledges that commercialization challenges could impact future success.
Read more →SINTSINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization Salt Lake City, UT
SINTX Technologies, Inc. has announced a business update detailing its strategic shift toward medical device commercialization, focusing on silicon nitride applications. The company reported improved financials, including a cash increase and reduced operating costs. Highlighting advanced research programs and partnerships with medical OEMs, SINTX aims to meet critical healthcare needs. However, the transition carries risks related to product commercialization and market acceptance.
Read more →SINTSINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules Salt Lake City, Utah
SINTX Technologies, Inc. announced the completion of a $5 million private placement under Nasdaq rules. This deal involved the sale of 1,449,287 shares at a price of $3.45 each, along with unregistered warrants. The company plans to utilize the proceeds for working capital and will file registration statements with the SEC for resale of the shares. Wainwright & Co. acted as the exclusive placement agent for this offering.
Read more →SINTSINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer Seasoned Healthcare Executive to Lead Strategic Growth Initiatives Salt Lake City, UT
SINTX Technologies has announced the appointment of Gregg R. Honigblum as Chief Strategy Officer. Honigblum, a seasoned healthcare executive with over 35 years of experience, will lead the company's strategic growth initiatives and enhance investor relations. His background includes significant fundraising for healthcare technologies and involvement in early-stage capital roles. The company's leadership expresses confidence that his experience will help elevate SINTX’s market position amidst ongoing uncertainties in the industry.
Read more →SINTSINTX Technologies Announces Stock Repurchase Program Salt Lake City, UT
SINTX Technologies, Inc. has announced a stock repurchase program authorized by its Board of Directors to buy back up to $500,000 of the company's outstanding common stock. This program, which represents approximately 20% of total outstanding shares, reflects SINTX's confidence in its strategic initiatives and commitment to enhancing shareholder value. The stock repurchases will depend on market conditions and other factors, with management retaining discretion over timing and amounts. This program aligns with SINTX's ongoing efforts to optimize its capital structure and return capital to shareholders.
Read more →SINTSINTX Technologies Announces Appointment of Eric K. Olson as Chief Executive Officer Salt Lake City, Utah.
SINTX Technologies has appointed Eric K. Olson as its new CEO and President, succeeding Dr. B. Sonny Bal, who will remain as Chairman of the Board. Olson, a seasoned entrepreneur with over 30 years in the medical device field, previously held executive roles at SINTX, aiding in its IPO in 2014. The Board expressed confidence in Olson's leadership skills to drive the company's growth and enhance shareholder value. Additionally, Gregg Honigblum has been designated as Board Advisor, leveraging his extensive financial advisory experience.
Read more →SINTSINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement Salt Lake City, Utah.
SINTX Technologies, Inc. has announced that it has regained compliance with the Nasdaq bid price requirement, a significant milestone for the company. The compliance was confirmed in a notice from Nasdaq on June 11, 2024, effectively closing a previously announced listing matter. However, SINTX remains under a Mandatory Panel Monitor for a year and must maintain the minimum bid price to avoid potential delisting.
Read more →SINTSINTX TECHNOLOGIES Announces Reverse Stock Split Effective
SINTX Technologies, Inc. has announced a 1-for-200 reverse stock split effective May 28, 2024. This action aims to bring the company into compliance with the Nasdaq Capital Market's minimum bid price requirements. The reverse split will reduce the number of outstanding shares significantly, from approximately 123 million to about 0.6 million, while not altering the authorized shares or par value. All stockholders will be impacted uniformly, and fractional shares will be rounded up to whole shares. Concerns remain regarding the company's compliance status and market perception following this decision.
Read more →SINTSINTX Technologies Announces Proposed Public Offering of Common Stock
SINTX Technologies has announced its intent to conduct a public offering of common stock. The proceeds from the offering are planned to support working capital and general corporate purposes, although the completion of this offering is contingent on market conditions. There are no guarantees regarding the offering's size or terms. SINTX has been engaging in strategic acquisitions to further its growth in advanced ceramics and medical applications.
Read more →SINTE xhibit 99.1 SINTX TECHNOLOGIES ANNOUNCES PRICING OF $4.0
SINTX Technologies, Inc. has announced the pricing of its public offering of 16 million units, each priced at $0.25. The offering includes common stock and warrants. Proceeds are expected to be approximately $4 million before costs, with the offering set to close on February 2, 2024. The company emphasizes that the offering is made in accordance with a recently effective SEC registration statement.
Read more →SINTSINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023
SINTX Technologies, Inc. has reported preliminary unaudited revenues of approximately $902,000 for Q4 2023 and $2.6 million for the full year 2023. This marks an 18% increase in Q4 revenue year-over-year and a 68% increase compared to 2022. The growth has been attributed to new product adoption across various markets, including aerospace and biomedical sectors. SINTX also expects continued revenue growth in 2024, particularly by re-engaging in the ballistic and body armor market as demand remains strong.
Read more →SINTSINTX TECHNOLOGIES ENTERS A LONG-TERM
SINTX Technologies, Inc. has entered a long-term supply agreement to provide silicon nitride components for jet engines, marking the company's expansion beyond biomedical implants into aerospace applications. This agreement follows a two-year process of qualification of SINTX's operational and quality management systems. Although the deal allows for flexibility in supply without minimum requirements, projected revenues are modest, estimated under $0.25 million annually. The agreement extends through 2026, with an option for renewal by the customer based on demand forecasts.
Read more →SINTSINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants
SINTX Technologies, Inc. has been awarded a Phase II grant of $1,972,826 by the NIH to further develop its 3D printed silicon nitride-polyetheretherketone (SN-PEEK) spinal implants. This grant follows a successful Phase I project, which demonstrated the reliability and biocompatibility of these composite implants. Over the next 24 months, SINTX will collaborate with the University of Pennsylvania School of Veterinary Medicine to validate the design and perform rigorous testing. The completion of this project aims to support FDA regulatory clearance and advance infection prevention claims for these spinal devices.
Read more →SINTSINTX Technologies Announces Pricing of $12.0 Million Public Offering
SINTX Technologies, Inc. has announced the pricing of its public offering, consisting of 2,150,000 units priced at $5.60 each. The offering is anticipated to generate approximately $12.0 million before expenses, expected to close on February 10, 2023. Each unit includes common stock and warrants, which will be immediately exercisable upon issuance. The offering is being conducted in accordance with SEC regulations, and while it presents opportunities for the company, there are inherent risks in product commercialization and acceptance in the market.
Read more →SINTSINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update
SINTX Technologies, Inc. announced preliminary unaudited financial results for Q4 and the full year of 2022, with revenues reported at approximately $770,000 and $1.6 million respectively. The company experienced growth throughout the year and attributed revenue increases to contracts in the biomedical field and contributions from a recent acquisition. Looking ahead, SINTX expects further revenue growth in 2023, especially in aerospace and energy markets, as it prepares to fully operationalize its Armor facility in Salt Lake City. However, these results are preliminary and subject to audits, which may lead to changes in the reported figures.
Read more →SINTSINTX TECHNOLOGIES Announces Reverse Stock Split Effective DECEMBER 20, 2022 SINTX common stock expected to begin trading on a split-adjusted basis on
TECHNOLOGIES Announces Reverse Stock Split Effective DECEMBER 20, 2022 common stock expected to begin trading on a split-adjusted basis on December 20, 2022 LAKE CITY, December 19, 2022 (GLOBE NEWSWIRE) - SINTX Technologies, Inc. (NASDAQ: SINT) today announced that its Board of
Read more →SINTSINTX TECHNOLOGIES Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering SALT LAKE CITY, UT, SEPTEMBER 12, 2022 (GLOBE NEWSWIRE) - SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Compa
TECHNOLOGIES Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering LAKE CITY, UT, SEPTEMBER 12, 2022 (GLOBE NEWSWIRE) - SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), an original equipment manufacturer of advanced ceramics, today
Read more →SINTSINTX Technologies Acquires Technology Assessment and Transfer, Inc. The Acquisition Broadens Opportunities for SINTX in Aerospace, Defense, and Biomedical Markets
Technologies Acquires Technology Assessment and Transfer, Inc. Acquisition Broadens Opportunities for SINTX in Aerospace, Defense, and Biomedical Markets LAKE CITY, July 6, 2022 (GLOBE NEWSWIRE) - SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) ("SINTX" or the "Company
Read more →SINTSINTX Technologies Ends Patent License Agreement With O2TODAY
Technologies Ends Patent License Agreement With O2TODAY LAKE CITY, November 5, 2021 (GLOBE NEWSWIRE) - SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) ("SINTX" or the "Company"), an original equipment manufacturer of advanced ceramics for medical and non-medical applica
Read more →SINTSINTX Technologies Shares Q3 2021 Revenue Update
Technologies Shares Q3 2021 Revenue Update LAKE CITY, Oct. 14, 2021 (GLOBE NEWSWIRE) - SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) ("SINTX" or the "Company"), an original equipment manufacturer of advanced ceramics, announced today preliminary Q3 2021 revenue result
Read more →SINTSINTX Technologies Announces Adjournment of Annual Meeting of Stockholders Due to Lack of Quorum
Technologies Announces Adjournment of Annual Meeting of Stockholders Due to Lack of Quorum LAKE CITY, September 15, 2021 (GLOBE NEWSWIRE) - SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) ("SINTX" or the "Company"), an original equipment manufacturer of advanced ceramic
Read more →SINTSINTX Technologies Reassesses Exclusive Patent License with O2TODAY
Technologies Reassesses Exclusive Patent License with O2TODAY LAKE CITY, August 5, 2021 (GLOBE NEWSWIRE) - SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) ("SINTX" or the "Company"), an original equipment manufacturer of advanced ceramics for medical and non-medical app
Read more →SINTSINTX Enters Ceramic Armor Market Through Purchase of Assets from B4C, LLC and Technology License from Precision Ceramics USA Inc. [Caption: SINTX will support the development and scale-up manufactu
Enters Ceramic Armor Market Through Purchase of Assets from B4C, LLC and Technology License from Precision Ceramics USA Inc. SINTX will support the development and scale-up manufacturing of high-performance ceramic armor for use by personnel, aircraft, and vehicles.] LAKE CITY,
Read more →SINTSINTX Technologies Announces the Sale of First Silicon Nitride Antipathogenic Powder to O2TODAY [Caption: Image of O2TODAY's mask prototype which will be available for limited pre-orders starting on
Technologies Announces the Sale of First Silicon Nitride Antipathogenic Powder to O2TODAY Image of O2TODAY's mask prototype which will be available for limited pre-orders starting LAKE CITY, June 30, 2021 (GLOBE NEWSWIRE) - SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT
Read more →SINTO2TODAY and SINTX Technologies Enter Commercialization Agreement to Fight COVID-19 (Caption: O2TODAY and SINTX executives signed an agreement to commercialize a "catch-and-kill" mask that will inactivate COVID-19 and oth
and SINTX Technologies Enter Commercialization Agreement to Fight COVID-19 O2TODAY and SINTX executives signed an agreement to commercialize a "catch-and-kill" mask that will inactivate COVID-19 and other respiratory viruses.) LAKE CITY, UT, February 25, 2021 (GLOBE NEWSWIRE)
Read more →SINTE xhibit 99.1 SHARE PURCHASE AGREEMENT This Share Purchase Agreement (this " Agreement ") is dated as of
Share Purchase Agreement (this "Agreement") is dated as of August 4, 2020, between SINTX Technologies, Inc., a Delaware corporation (the "Company"), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a "Purchaser" and collec
Read more →SINTO2TODAY ANNOUNCES AGREEMENT TO DEVELOP ANTIMICROBIAL FACE MASKS WITH SINTX TECHNOLOGIES INC. TO HELP PREVENT SPREAD OF COVID-19
ANNOUNCES AGREEMENT TO DEVELOP ANTIMICROBIAL FACE MASKS WITH SINTX TECHNOLOGIES INC. TO HELP PREVENT SPREAD OF COVID-19 AND OTHER LAKE CITY, UT, August 4, 2020 (GLOBE NEWSWIRE) - O2TODAY (www.O2TODAY.com), an original equipment manufacturer (OEM) company who develops and commer
Read more →SINTSHARE PURCHASE AGREEMENT This Share Purchase Agreement (this " Agreement ") is dated as of
Share Purchase Agreement (this "Agreement") is dated as of July 16, 2020, between SINTX Technologies, Inc., a Delaware corporation (the "Company"), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a "Purchaser" and collect
Read more →SINTSINTX Technologies Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement
Technologies Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement LAKE CITY, UT July 14, 2020 (GLOBE NEWSWIRE) - SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), an original equipment manufacturer (OEM) ceramics company focused on silicon nitr
Read more →SINTSINTX Technologies Announces SARS-CoV-2 Testing Results
Technologies Announces SARS-CoV-2 Testing Results LAKE CITY, UT, June 20, 2020 (GLOBE NEWSWIRE) - SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride and its applications, today
Read more →SINTSINTX TECHNOLOGIES RELEASES PRELIMINARY 2019 YEAR END EARNINGS REPORT AND A
TECHNOLOGIES RELEASES PRELIMINARY 2019 YEAR END EARNINGS REPORT AND A BUSINESS UPDATE LAKE CITY, UT March 4, 2020 (GLOBE NEWSWIRE) - SINTX Technologies, Inc. (NASDAQ: SINT) (the "Company"), an original equipment manufacturer (OEM) ceramics company that develops and commercializ
Read more →SINTSINTX TECHNOLOGIES ANNOUNCES AGREEMENT TOWARD A COLLABORATION WITH NISSIN MANUFACTURING CO.
TECHNOLOGIES ANNOUNCES AGREEMENT TOWARD A COLLABORATION WITH NISSIN MANUFACTURING CO., LTD. LAKE CITY, UT, January 30, 2020 (GLOBE NEWSWIRE) - SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), an original equipment manufacturer (OEM) ceramics company that deve
Read more →SINTSINTX TECHNOLOGIES Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
TECHNOLOGIES Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering LAKE CITY, UT, December 27, 2019 (GLOBE NEWSWIRE) - SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), an original equipment manufacturer (OEM) ceramics company that d
Read more →SINTSINTX TECHNOLOGIES RELEASES 2019 THIRD QUARTER AND YEAR-TO-DATE
SINTX TECHNOLOGIES RELEASES 2019 THIRD QUARTER AND YEAR-TO-DATE EARNINGS REPORT AND PROVIDES BUSINESS UPDATE SALT LAKE CITY, UT November 18, 2019 (GLOBE NEWSWIRE) - SINTX Technologies, Inc. (NASDAQ: SINT) (the "Company"), an original equipment manufacturer (OEM) ceramics comp
Read more →SINTSINTX TECHNOLOGIES RELEASES 2019 YTD EARNINGS REPORT Company also announced that it has regained compliance with Nasdaq Listing Requirements
TECHNOLOGIES RELEASES 2019 YTD EARNINGS REPORT also announced that it has regained compliance with Nasdaq Listing Requirements SALT LAKE CITY, UT August 15, 2019 (GLOBE NEWSWIRE) - SINTX Technologies, Inc. (NASDAQ: SINT) (the "Company"), an OEM ceramics company that develops a
Read more →SINTSINTX TECHNOLOGIES Announces Reverse Stock Split Effective Today SINTX common stock expected to begin trading on a split-adjusted basis on
TECHNOLOGIES Announces Reverse Stock Split Effective Today common stock expected to begin trading on a split-adjusted basis on July 29, 2019 LAKE CITY, July 26, 2019 (GLOBE NEWSWIRE) - SINTX Technologies, Inc. (NASDAQ: SINT) today announced that its Board of Directors has decl
Read more →SINTSINTX TECHNOLOGIES ANNOUNCES STOCKHOLDERS APPROVE REVERSE STOCK SPLIT SINTX also announces promotion of David O'Brien to Chief Operating Officer
TECHNOLOGIES ANNOUNCES STOCKHOLDERS APPROVE REVERSE STOCK SPLIT also announces promotion of David O'Brien to Chief Operating Officer LAKE CITY, July 15, 2019 (GLOBE NEWSWIRE) - SINTX Technologies, Inc. (NASDAQ: SINT) today announced that its stockholders voted in favor of gra
Read more →SINTSINTX TECHNOLOGIES ANNOUNCES ADJOURNMENT OF ANNUAL MEETING OF STOCKHOLDERS UNTIL JULY 3, 2019 Annual Meeting adjourned solely with respect to Proposal 2 - Approval of Reverse Stock Split
TECHNOLOGIES ANNOUNCES ADJOURNMENT OF ANNUAL MEETING OF STOCKHOLDERS UNTIL JULY 3, 2019 Meeting adjourned solely with respect to Proposal 2 - Approval of Reverse Stock Split LAKE CITY, June 27, 2019 (GLOBE NEWSWIRE) - SINTX Technologies, Inc. (NASDAQ: SINT) today announced that
Read more →SINTSINTX TECHNOLOGIES RENEWS LEASE WITH PORTFOLIO INVESTMENTS AT CENTREPOINTE BUSINESS PARK SALT LAKE CITY, Utah (
TECHNOLOGIES RENEWS LEASE WITH PORTFOLIO INVESTMENTS AT CENTREPOINTE BUSINESS PARK LAKE CITY, Utah (June 10, 2019) - SINTX Technologies, Inc., a ceramics OEM company that develops and manufactures silicon nitride, announced today that the Company renewed its lease with Portfol
Read more →SINTSINTX TECHNOLOGIES ANNOUNCES ADJOURNMENT OF ANNUAL MEETING OF STOCKHOLDERS UNTIL MAY 23, 2019 3 of 4 Proposals pass with stockholder approval Annual Meeting adjourned solely with respect to Proposal 2 - Approval of Rever
TECHNOLOGIES ANNOUNCES ADJOURNMENT OF ANNUAL MEETING OF STOCKHOLDERS UNTIL MAY 23, 2019 of 4 Proposals pass with stockholder approval Meeting adjourned solely with respect to Proposal 2 - Approval of Reverse Stock Split LAKE CITY, April 24, 2019 (GLOBE NEWSWIRE) - SINTX Techno
Read more →SINTAmedica Receives Nasdaq Listing Determination; Plans to Request Hearing
Receives Nasdaq Listing Determination; LAKE CITY, August 25, 2017 - Amedica Corporation (Nasdaq: AMDA) (the "Company"), an innovative biomaterial company that develops and manufactures silicon nitride as a platform for biomedical applications, disclosed today that on August 22
Read more →SINTAMENDING and REPLACING - AMEDICA RELEASES 2016 PRELIMINARY UNAUDITED EARNINGS REPORT AND BUSINESS UPDATE SALT LAKE CITY, UT - (Marketwired) - 06/09/17 1 - Amedica Corporation (NASDAQ: AMDA), a company that develops and c
and REPLACING - AMEDICA RELEASES 2016 PRELIMINARY UNAUDITED EARNINGS REPORT AND BUSINESS UPDATE LAKE CITY, UT - (Marketwired) - 06/09/171 - Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride for biomedical applications, today announce
Read more →SINTAMEDICA RELEASES 2016 PRELIMINARY EARNINGS REPORT AND BUSINESS UPDATE SALT LAKE CITY, UT - (Marketwired) - 06/08/17 - Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride for bio
RELEASES 2016 PRELIMINARY EARNINGS REPORT AND BUSINESS UPDATE LAKE CITY, UT - (Marketwired) - 06/08/17 - Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride for biomedical applications, today announced its preliminary earnings report f
Read more →SINTAmedica Announces Delayed Filing of Quarterly Report on Form 10-Q and Receipt of Nasdaq Letter
Announces Delayed Filing of Quarterly Report on Form 10-Q and Receipt of Nasdaq Letter LAKE CITY, May 26, 2017 - Amedica Corporation (Nasdaq:AMDA), an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical applications, annou
Read more →SINTAmedica Announces Delayed Filing of Annual Report on Form 10-K and Receipt of Nasdaq Letter
Announces Delayed Filing of Annual Report on Form 10-K and Receipt of Nasdaq Letter LAKE CITY, April 19, 2017 - Amedica Corporation (Nasdaq:AMDA), an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical applications, announ
Read more →SINTAmedica Announces Results of Independent Femoral Head Wear Testing
Announces Results of Independent Femoral Head Wear Testing LAKE CITY, February 27, 2017 - Amedica Corporation (Nasdaq:AMDA), an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical applications, announced today that Researc
Read more →SINTAmedica Granted 180-Day Extension by NASDAQ to Regain Compliance with Minimum Bid Price Rule
Granted 180-Day Extension by NASDAQ to Regain Compliance with Minimum Bid Price Rule LAKE CITY, February 15, 2017 - Amedica Corporation (Nasdaq:AMDA), an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical applications, an
Read more →SINTAmedica announces Pricing of Public Offering to Raise $4.5 Million SALT LAKE CITY, UT - 01/19/17 - Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics, today announced
announces Pricing of Public Offering to Raise $4.5 Million LAKE CITY, UT - 01/19/17 - Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics, today announced the pricing of an underwritten public offering of common stock and warr
Read more →SINTAmedica announces proposed public offering of common stock AND WARRANTS SALT LAKE CITY, UT - 01/18/17 - Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics, today annou
announces proposed public offering of common stock AND WARRANTS LAKE CITY, UT - 01/18/17 - Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics, today announced that it intends to offer and sell common stock and warrants, subje
Read more →SINTAmedica Announces Positive Scientific Data and Re-files FDA Submission
Announces Positive Scientific Data and Re-files FDA Submission LAKE CITY, December 19, 2016 - Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced encouraging results from a recent study sho
Read more →SINTAmedica Announces New Sales Leadership and Provides Regulatory Updates SALT LAKE CITY, (Marketwired) --11/22/16-- Amedica Corporation (NASDAQ: AMDA), a manufacturer of silicon nitride implants in the spine market is plea
Announces New Sales Leadership and Provides Regulatory Updates LAKE CITY, (Marketwired) --11/22/16-- Amedica Corporation (NASDAQ: AMDA), a manufacturer of silicon nitride implants in the spine market is pleased to announce the appointment of Dana Lyons as Vice President of Sal
Read more →SINTAmedica Corporation Reports Third Quarter 2016 Financial Results Year-to-date Operational Cash Burn Improved by 25% Year-Over-Year
Corporation Reports Third Quarter 2016 Operational Cash Burn Improved by 25% Year-Over-Year LAKE CITY, November 10, 2016 - Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced financia
Read more →SINTAmedica Announces Workforce Reduction SALT LAKE CITY, (Marketwired) - 10/05/16 - Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company that develops and commercializes silicon nitride as a platform for bi
Announces Workforce Reduction LAKE CITY, (Marketwired) - 10/05/16 - Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company that develops and commercializes silicon nitride as a platform for biomedical applications, today announced that it is reducing its workforc
Read more →SINTAmedica Receives FDA Clearance for Additional Valeo II Lateral Lumbar Interbody Fusion Device Offerings Additional sizes provide greater accommodation for a wider range of patient anatomies
Receives FDA Clearance for Additional Valeo II Lateral Lumbar Interbody Fusion Device Offerings sizes provide greater accommodation for a wider range of patient anatomies LAKE CITY, August 24, 2016 - Amedica Corporation (Nasdaq:AMDA), an innovative biomaterial company that deve
Read more →SINTAmedica Announces Receipt of Nasdaq Notice of Bid Price Deficiency
Announces Receipt of Nasdaq Notice of Bid Price Deficiency LAKE CITY, August 19, 2016 - Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today that on August 17, 2016, the Company receive
Read more →SINTAmedica Corporation Reports Second Quarter 2016 Financial Results Year-to-date Operational Cash Burn Improved by 55% Year-Over-Year
Corporation Reports Second Quarter 2016 Financial Results Operational Cash Burn Improved by 55% Year-Over-Year LAKE CITY, August 11, 2016 - Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today a
Read more →SINTAmedica Announces Closing of $12.7 Million Public Offering and Full Exercise of Over-Allotment Option Total Debt Principal Balance Decreased to $10 Million
Announces Closing of $12.7 Million Public Offering and Full Exercise of Over-Allotment Option Debt Principal Balance Decreased to $10 Million LAKE CITY, July 8, 2016 - Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics, toda
Read more →SINTAmedica Announces Pricing of $11 Million Public Offering
Announces Pricing of $11 Million Public Offering LAKE CITY, July 5, 2016 - Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics, today announced the pricing of an underwritten public offering of units for gross proceeds of $11
Read more →SINTAmedica Submits Response to FDA for Clearance of Composite Interbody Spinal Device Porous Silicon Nitride Demonstrates Healing and Fusion Outcomes Similar to Autograft Bone
Submits Response to FDA for Clearance of Composite Interbody Spinal Device Silicon Nitride Demonstrates Healing and Fusion Outcomes Similar to Autograft Bone LAKE CITY, June 13, 2016 - Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitrid
Read more →SINTAmedica Corporation Reports First Quarter 2016 Financial Results Q1 Operational Cash Burn Improved by 51% Year-over-Year
Corporation Reports First Quarter 2016 Financial Results Operational Cash Burn Improved by 51% Year-over-Year LAKE CITY, May 12, 2016 - Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today annou
Read more →SINTAmedica Completes Debt Exchange and Reduces Debt Obligations by 47% Year-over-Year
Debt Exchange and Reduces Debt by 47% Year-over-Year SALT LAKE CITY, May 3, 2016 - Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce it has reduced its total debt obligation
Read more →SINTAmedica Signs Exclusive Chinese Silicon Nitride Distribution Agreement 10-Year Exclusive Agreement to Represent Significant Global Sales Expansion and Minimum Purchase Requirements
Signs Exclusive Chinese Silicon Nitride Distribution Agreement Exclusive Agreement to Represent Significant Global Sales Expansion and Minimum Purchase Requirements LAKE CITY, April 18, 2016 - Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon
Read more →SINTAmedica Enters Debt Exchange Agreement Agreement to Unlock Additional Working Capital and Allow for Future Debt Refinance
Enters Debt Exchange Agreement to Unlock Additional Working Capital and Allow for Future Debt Refinance LAKE CITY, April 5, 2016 - Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to an
Read more →SINTAmedica First to 3D Print Silicon Nitride for Medical Applications Company Plans to Use 3D Printing Technology for its Proprietary Silicon Nitride Devices
First to 3D Print Silicon Nitride for Medical Applications Plans to Use 3D Printing Technology for its Proprietary Silicon Nitride Devices LAKE CITY, March 23, 2016 - Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a bi
Read more →SINTAmedica Corporation Reports Fourth Quarter and Full Year 2015 Financial Results 2015 Revenue of $19.5 Million at High End of Guidance Operational Cash Burn Decreases by 38%
Reports Fourth Quarter and Full Year 2015 Financial Results 2015 Revenue of $19.5 Million at High End of Guidance Operational Cash Burn Decreases by 38% SALT LAKE CITY, March 17, 2016 - Amedica Corporation (Nasdaq: AMDA), a company that develops and commercializes silicon ni
Read more →SINTAmedica to Present Advantages of Silicon Nitride Implants at 2016 Brazilian Spine Congress Company Experiences Positive Sales Impact from Recent Brazil Clearance
Amedica to Present Advantages of Silicon Nitride Implants at 2016 Brazilian Spine Congress Company Experiences Positive Sales Impact from Recent Brazil Clearance SALT LAKE CITY, February 23, 2016 - Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes si
Read more →SINTAmedica Regains Compliance with NASDAQ Listing Requirements and Announces Capitalization Improvements Company Completes Share Consolidation and Improves Key Operational Metrics
Amedica Regains Compliance with NASDAQ Listing Requirements and Announces Capitalization Improvements Company Completes Share Consolidation and Improves Key Operational Metrics SALT LAKE CITY, February 9, 2016 - Amedica Corporation (Nasdaq:AMDA), a company that develops and com
Read more →SINT(Former Name or Former Address, if Changed Since Last Report)
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 28, 2016 (Exact name of registrant as specified in its charter) Delaware 001-33624 84
Read more →SINTAmedica Enhances Valeo II Product Family with the Addition of Its Second Generation Cervical System Valeo II C Interbody Further Improves Imaging and Fusion Assessment Capabilities
Amedica Enhances Valeo II Product Family with the Addition of Its Second Generation Cervical System Valeo II C Interbody Further Improves Imaging and Fusion Assessment Capabilities SALT LAKE CITY, January 25, 2016 - Amedica Corporation (Nasdaq:AMDA), a company that develops and
Read more →SINTAmedica Signs International Private Label Supply Agreement with Chinese Orthopedic Company Strategic Agreement to Provide Silicon Nitride Spinal Interbody Fusion Devices
Amedica Signs International Private Label Supply Agreement with Chinese Orthopedic Company Strategic Agreement to Provide Silicon Nitride Spinal Interbody Fusion Devices SALT LAKE CITY, December 30, 2015 - Amedica Corporation (Nasdaq:AMDA), a company that develops and commercia
Read more →SINTAmedica Corporation Amends Series A and C Warrants Amended Terms Fix Exercise Prices and Cap Number of Issuable Shares
Amedica Corporation Amends Series A and C Warrants Amended Terms Fix Exercise Prices and Cap Number of Issuable Shares SALT LAKE CITY, December 14, 2015 - Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial pla
Read more →SINTAmedica Submits 24-Month Clinical Data to FDA for Clearance of Composite Interbody Spinal Device Silicon Nitride Demonstrates Fusion Outcomes Similar to Autograft Bone
Amedica Submits 24-Month Clinical Data to FDA for Clearance of Composite Interbody Spinal Device Silicon Nitride Demonstrates Fusion Outcomes Similar to Autograft Bone SALT LAKE CITY, November 10, 2015 - Amedica Corporation (Nasdaq:AMDA), a company that develops and commerciali
Read more →SINTAmedica Corporation Signs Additional Silicon Nitride Private Label Agreement Newest Alliance to Positively Impact Future Financial Results
Amedica Corporation Signs Additional Silicon Nitride Private Label Agreement Newest Alliance to Positively Impact Future Financial Results SALT LAKE CITY, November 5, 2015 - Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics a
Read more →SINTAmedica Launches Innovative Articulating Inserter for Minimally Invasive TLIF Procedures Scorpion Articulating Inserter Improves Visibility and Access while Reducing Impact on Patient
Amedica Launches Innovative Articulating Inserter for Minimally Invasive TLIF Procedures Scorpion Articulating Inserter Improves Visibility and Access while Reducing Impact on Patient SALT LAKE CITY, October 13, 2015 - Amedica Corporation (Nasdaq:AMDA), a company that develops
Read more →SINTAmedica Breaks into the Dental Market with Recent Joint Development Agreement Marks First Step for Silicon Nitride to be used in a Variety of Medical Applications
Amedica Breaks into the Dental Market with Recent Joint Development Agreement Marks First Step for Silicon Nitride to be used in a Variety of Medical Applications SALT LAKE CITY, October 12, 2015 - Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes si
Read more →SINTDr.
Amedica Corporation Adds Giuseppe Pezzotti, PhD to its Scientific Advisory Board Dr. Pezzotti to Present Webcast on September 15, 2015 highlighting Silicon Nitride Technology SALT LAKE CITY, September 9, 2015 -- Amedica Corporation (Nasdaq:AMDA), a company that develops and com
Read more →SINTAmedica Enters into Definitive Agreements to Raise $15.0 Million in Equity Financing
Amedica Enters into Definitive Agreements to Raise $15.0 Million in Equity Financing SALT LAKE CITY, September 8, 2015 - Amedica Corporation (Nasdaq:AMDA), an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical applications
Read more →SINTAmedica Announces Preliminary Q2 2015 Financial Results and Update on Recent FDA Response Year-to-Date Operational Cash Burn Levels Decreased by Approximately 40% Year-over-Year
Amedica Announces Preliminary Q2 2015 Financial Results and Update on Recent FDA Response Year-to-Date Operational Cash Burn Levels Decreased by Approximately 40% Year-over-Year SALT LAKE CITY, July 27, 2015 - Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has de
Read more →SINTAmedica Corporation Provides Update on FDA Inquiries and Femoral Head Testing Protocol Feedback
Amedica Corporation Provides Update on FDA Inquiries and Femoral Head Testing Protocol Feedback SALT LAKE CITY, July 7, 2015 -- Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced that
Read more →SINTAmedica Corporation Reports Fourth Quarter and Full Year 2014 Financial Results Full Year Silicon Nitride Ceramic Revenue Increases 41% Year-Over-Year
Amedica Corporation Reports Fourth Quarter and Full Year 2014 Financial Results Full Year Silicon Nitride Ceramic Revenue Increases 41% Year-Over-Year SALT LAKE CITY, March 5, 2015 -- Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride
Read more →SINTAmedica Submits 510(k) Application to FDA for Composite Spinal Interbody Spacers with Porous Silicon Nitride Center
Amedica Submits 510(k) Application to FDA for Composite Spinal Interbody Spacers with Porous Silicon SALT LAKE CITY, February 12, 2015 Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced tod
Read more →SINTAmedica Becomes First to Receive FDA Clearance for Two-Level Cervical Interbody Cage Indications FDA Clearance Provides Additional Point of Differentiation in the Marketplace and a Valuable On-label Treatment Option for
Amedica Becomes First to Receive FDA Clearance for Two-Level Cervical Interbody Cage Indications FDA Clearance Provides Additional Point of Differentiation in the Marketplace and a Valuable On-label Treatment Option for Surgeons SALT LAKE CITY, February 3, 2015 Amedica Corporat
Read more →SINTAmedica Announces Steps to Simplify Organization and Align Financial Objectives
Amedica Announces Steps to Simplify Organization and Align Financial Objectives SALT LAKE CITY, January 12, 2015 Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced the results of a co
Read more →SINTAmedica s Spinal Interbody Spacers with Porous Silicon Nitride Center Provide Equivalent Fusion to PEEK Spacers with Bone Autograft
Amedica s Spinal Interbody Spacers with Porous Silicon Nitride Center Provide Equivalent Fusion to PEEK Spacers with Bone Autograft SALT LAKE CITY, January 5, 2015 Amedica Corporation (Nasdaq: AMDA), a biomaterial company that develops and commercializes silicon nitride cerami
Read more →SINTAmedica Announces Preliminary Q4 & FY 2014 Financial Results and Update on CASCADE Clinical Study
Amedica Announces Preliminary Q4 & FY 2014 Financial Results and Update on CASCADE Clinical Study SALT LAKE CITY, December 18, 2014 Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and com
Read more →SINTAmedica Corporation Reports Third Quarter 2014 Financial Results Q3 Silicon Nitride Ceramic Revenue Increases 57% Year-Over-Year
Amedica Corporation Reports Third Quarter 2014 Financial Results Q3 Silicon Nitride Ceramic Revenue Increases 57% Year-Over-Year SALT LAKE CITY, November 6, 2014 Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride ceramics as a material
Read more →SINTAmedica Corporation Announces Private Label Agreement with Spinal Kinetics Strategic Agreement to Provide Silicon Nitride Spinal Interbody Fusion Devices
Amedica Corporation Announces Private Label Agreement with Spinal Kinetics Strategic Agreement to Provide Silicon Nitride Spinal Interbody Fusion Devices SALT LAKE CITY, October 14, 2014 Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride
Read more →SINTAmedica Corporation Appoints Eric A. Stookey to the Board of Directors
Amedica Corporation Appoints Eric A. Stookey to the Board of Directors SALT LAKE CITY, October 7, 2014 Amedica Corporation (Nasdaq: AMDA), a biomaterial company focused on silicon nitride ceramics as a material platform to develop, manufacture and commercialize novel medical de
Read more →SINTAmedica Corporation Appoints New President and Chief Executive Officer
Amedica Corporation Appoints New President and Chief Executive Officer SALT LAKE CITY, September 30, 2014 Amedica Corporation (Nasdaq:AMDA), a commercial biomaterial company focused on using its Silicon Nitride technology platform to develop, manufacture and sell a broad range
Read more →SINTAmedica Corporation Reports Second Quarter 2014 Financial Results Proprietary Silicon Nitride Ceramic Product Revenue Increases 51% Over Second Quarter 2013
Amedica Corporation Reports Second Quarter 2014 Financial Results Proprietary Silicon Nitride Ceramic Product Revenue Increases 51% Over Second SALT LAKE CITY, August 7, 2014 Amedica Corporation (Nasdaq:AMDA), a commercial biomaterial company focused on using its silicon nitr
Read more →SINTAMEDICA SECURES $26 MILLION IN FUNDING $20 Million Debt Facility with Hercules Technology Growth Capital $6 Million Private Placement of Senior Convertible Notes to Magna Salt Lake City, UT
AMEDICA SECURES $26 MILLION IN FUNDING $20 Million Debt Facility with Hercules Technology Growth Capital $6 Million Private Placement of Senior Convertible Notes to Magna Salt Lake City, UT, July 1, 2014 Amedica Corporation (NASDAQ: AMDA) a biomaterial company focused on using
Read more →SINT: 06-05-14 AMEDICA ANNOUNCES TERMINATION OF BIOLOGIC DISTRIBUTION AGREEMENT New strategy allows company to sharpen focus on porous Silicon Nitride bioceramic technology Salt Lake City
For Immediate Release: 06-05-14 AMEDICA ANNOUNCES TERMINATION OF BIOLOGIC DISTRIBUTION AGREEMENT New strategy allows company to sharpen focus on porous Silicon Nitride bioceramic technology Salt Lake City, June 5, 2014 Amedica Corporation (NASDAQ: AMDA), a commercial biomateri
Read more →SINT: 05-15-14 AMEDICA CORPORATION REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS Proprietary Silicon Nitride Ceramic Product Revenue Increases 41% Over First Quarter 2013 Total Revenue Increases 10% versu
For Immediate Release: 05-15-14 AMEDICA CORPORATION REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS Proprietary Silicon Nitride Ceramic Product Revenue Increases 41% Over First Quarter 2013 Total Revenue Increases 10% versus First Quarter 2013 Salt Lake City, May 15, 2014 Amedic
Read more →SINTAmedica Reports Fourth Quarter and Full Year 2013 Financial Results Fourth Quarter 2013 Total Revenue was $5.7 Million, an Increase of 8% Compared with $5.3 Million in Third Quarter 2013 Silicon Nitride Product Sales Inc
Amedica Reports Fourth Quarter and Full Year 2013 Financial Results SALT LAKE CITY, March 31, 2014 (GLOBE NEWSWIRE) Amedica Corporation (Nasdaq:AMDA), a biomaterials company, today announced financial results for the fourth quarter and full year ended December 31, 2013. Eric O
Read more →Competitive Position
How SINT ranks across every disease it competes inCompetitive Position is a premium feature
See how SINT ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial